Ignite Creation Date:
2025-12-24 @ 10:44 PM
Ignite Modification Date:
2025-12-25 @ 8:15 PM
Study NCT ID:
NCT05691335
Status:
COMPLETED
Last Update Posted:
2023-03-31
First Post:
2023-01-07
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Three Different Cross-linking Protocols for Treatment of Pediatric Keratoconus
Sponsor:
Sohag University
Organization:
Study Overview
Official Title:
Analysis of the Outcomes of Three Different Cross-linking Protocols for Treatment of Pediatric Keratoconus
Status:
COMPLETED
Status Verified Date:
2023-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
comparison between standard cross-linking protocol and accelerated and transepithelial cross-linking
Detailed Description:
comparison between standard cross-linking protocol and accelerated and transepithelial cross-linking for treatment of documented pediatric keratoconus progression. The study patients are divided into 3 groups. Group A patient treated with standard cross-linking. Group B patients treated with accelerated cross-linking. Group C patients treated with transepithelial cross-linking.
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: